本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LB Pharmaceuticals Inc

44.63
-1.6200-3.50%
盤後44.630.00000.00%18:00 EDT
成交量:20.84萬
成交額:940.23萬
市值:14.40億
市盈率:-14.94
高:47.68
開:46.80
低:44.40
收:46.25
52周最高:50.16
52周最低:13.36
股本:3,225.92萬
流通股本:2,162.18萬
量比:0.90
換手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):-2.9880
每股收益(LYR):-3.1329
淨資產收益率:-50.00%
總資產收益率:-29.98%
市淨率:4.33
市盈率(LYR):-14.25

資料載入中...

2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/07/16

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/04/11

SEC問詢函

Form CORRESP - Correspondence
2026/04/06

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans